Close
Help




JOURNAL

Biochemistry Insights

Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection

Submit a Paper


Biochemistry Insights 2015:Suppl. 1 25-29

Review

Published on 04 Feb 2016

DOI: 10.4137/BCI.S30753

Correction


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Biochemistry Insights

Abstract

Carbamylated erythropoietin (cEpo), which is neuroprotective but lacks hematopoietic activity, has been attracting rising concerns. However, the cellular and molecular mechanisms involved in the process of neuroprotection of cEpo are not well known. Based on several recent reports, the neuroprotective effects of cEpo are illustrated, and signaling pathways involved in the different effects of erythropoietin and cEpo are discussed. These newly reported researches may shed new light on the development and application of cEpo, a prospective drug candidate for neuroprotection.



Downloads

PDF  (1.06 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML




Quick Links


New article and journal news notification services